HEOR(Health Economics and Outcome Research)
LITERATURE REVIEWS:
We recognise the value of health economics and real-world evidence in achieving market access.
Obtaining reimbursement requires demonstrating the product’s clinical and economic benefits.
Our HEOR analysts have a track record of performing systematic and focused literature reviews.
They are proficient in tools such as RevMan, WinBugs, and STATA.
Literature Search
- Cross References
- PubMed (MEDLINE)
- EMBASE
- Grey Literature
- Cochrane Library
- Conference Abstracts
- ClinicalTrials.gov
Review Types
- Network Meta-Analysis (NMA)
- Systematic Literature Reviews
- Meta-Analysis
- Targeted Literature Reviews
- Mixed Treatment Comparison
- Narrative Reviews
- Indirect Treatment Comparison
Type of Studies
- Comparative Safety
- Burden of Illness
- Comparative Effectiveness
- Cost of Illness
- Comparative Effectiveness
- Treatment Patterns
- Comparative Effectiveness
- Clinical Outcomes
HEOR Writing
- White Papers
- Systematic Literature Review Report
- Survey Reports
- Custom Literature Reports
- Conference Abstracts and Posters
- RWE Manuscripts
- Health Evaluation Manuscripts
ECONOMIC MODELING
Maven Healthcare can create health economic modelling solutions to enable market-specific reimbursement, improved market access, and high-impact scientific publications.
- Cost of Illness Analysis (COI)
- Country Specific Modeling Adaptations
- Cost Effective Analysis (CEA)
- Disease Burden Models
- Cost Benefit Analysis (CBA)
- Budget Impact Models
- Cost Utility Analysis (CUA)
- Cost Consequence Analysis (CCA)
- Cost Minimization Analysis (CMA)
REAL WORLD EVIDENCE
In health-care decisions, real-world data (RWD) and real-world evidence (RWE) are becoming increasingly important.
We may collect RWE for life science industry clients by reviewing claims and medical records and communicating the results to enable value demonstration.
Data Collection
- Electronic Health Data
- Medical Chart Abstraction
- Patient Registries
- Patient or Physician Survey
Data analytics
- Quality of Life
- Patient Profiling
- Resource Utilization
- Clinical Outcomes
- Effectiveness and Long-Term Safety
- Endpoint Assessment
Type Of Studies
- Prospective and Retrospective studies
- Patient or Physician Surveys
- Medical Chart Review Studies
- Registries
PRICING, REIMBURSEMENT AND MARKET ACCESS
We recognize the value of health economics and real-world evidence in achieving market access.
Obtaining reimbursement requires demonstrating the product’s clinical and economic benefits.
Market Access
- KOL Mapping
- Market Access Landscape Assessment
- Disease Mapping
- HTA monitoring
- Unmet Needs Mapping
Value Communication
- HTA Submissions
- Value Story Development
- Local Value Dossiers
- Global Value Dossiers
- Stakeholder Communication
Pricing and Reimbursement
- Product Assessment
- Payer Research
- Pricing Research
- Competitive Landscape Assessment
Market Research
- Analysis and Reporting
- Competitive Landscape
- Product Feedback
- In-Depth Interviews
- KOL Opinion
